Receipt of $1M Loan and Proposed Issue of Convertible Notes
Released
Released
Announcement PDF
ASX ANNOUNCEMENT
16 April 2026
Receipt of $1M Loan and Proposed Issue of Convertible
Notes
HITIQ Limited (ASX: HIQ) advises that it has received a $1M loan (Loan) from No Bull Health Pty Ltd, an
associate of Harmil Angel Investments Pty Ltd a substantial shareholder of the Company (collectively
Harmil). The key terms of the Loan are summarised in the schedule to this announcement.
An initial $250,000 of the Loan has been advanced to the Company to provide near-term working capital
support. The Loan is being made on the basis that it is intended to repaid by an issue of convertible notes
to Harmil, subject to obtaining the necessary shareholder and regulatory approvals.
The convertible notes are proposed to have substantially the same terms and conditions as the
convertible notes currently held by Harmil as set out in the Company’s Notice of General Meeting
released to ASX on 8 January 2026.
The Company intends to convene an extraordinary general meeting of shareholders in the coming
months to seek the required shareholder approvals for the issue of the convertible notes to Harmil. Full
details of the proposed transaction, including the final terms of the convertible notes, will be set out in
the notice of meeting.
The funds received under the Loan will be applied towards the Company’s working capital requirements
and ongoing business operations.
HITIQ’s Executive Chair, Earl Eddings said, “We thank Harmil for their ongoing support of the Company.
Accessing this additional funding as part of our overall capital management plan was viewed by the
Board as prudent given the challenging capital markets."
About PROTEQT™
PROTEQT™, co-developed with Shock Doctor, is HITIQ's concussion management and athlete safety
solution that delivers real-time head impact data through an instrumented mouthguard and analytics
platform.
About HITIQ
HITIQ Limited (ASX: HIQ) develops concussion management and athlete safety technology for sport,
clinical, and research applications worldwide. The company combines smart mouthguards and
analytics platforms to deliver data-driven safety solutions.
Authorised for release by the Board of HITIQ Limited
For further information, contact: investors@hitiq.com
Forward-Looking Statements Disclaimer
This announcement may contain forward-looking statements. Such statements involve known and
unknown risks, uncertainties, and other factors that may cause actual outcomes to differ materially.
HITIQ does not undertake any obligation to update forward-looking statements, except as required by
law.
SCHEDULE – KEY LOAN TERMS
Term Description
Loan Amount $1,000,000
Termination Date 6 months after execution.
Interest 12.50.% per annum with minimum interest amount of $100,000.
Repayment Subject to receipt of shareholder and regulatory approvals, the Loan
amount and accrued interest will be repaid by the issue of convertible
notes. Absent such approval the Loan and any accrued interest will be
repayable in cash at or before the Maturity Date.
Terms of convertible notes The convertible notes are proposed to have substantially the same
terms and conditions as the convertible notes currently held by
Harmil (see Schedule 1 of the Company’s Notice of General Meeting
released to ASX on 8 January 2026).
Security To be secured on the substantially the same terms as the security for
the existing convertible notes, with a general security deed over all
the assets of the Company. The grant of the security will be subject to
receipt of shareholder and regulatory approvals, and the Loan is
unsecured until then.
The final terms of the convertible notes and security will be set out in the notice of the extraordinary
general meeting at which shareholder approval for the issue of the convertible notes is sought.
Share your feedback
Discover